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Background: Our objective was to evaluate whether referring physician specialty impacts the use of non-invasive as well as invasive downstream 
testing after exercise treadmill testing (ETT).
methods: All consecutive patients with no prior history of CAD (N=3, 651) who were referred for clinical ETT at a large academic medical 
center over a 2 year period were included. Downstream imaging tests included nuclear perfusion imaging, coronary CT angiography, stress 
echocardiography, stress MRI, and invasive coronary angiography (IA) performed up to 6 months after the initial ETT. Referring physicians were 
categorized as cardiologists and non-cardiologists.
results: The ETT results were negative in 2876 (79%), positive in 132 (3.6%) and inconclusive in 643 (18%) of patients. Patients referred by non-
cardiologists had a similar number of normal (78.8% vs. 78.8%), positive (3.6% vs. 3.7%) and inconclusive ETT results (17.7% vs. 17.5) (p=0.998). 
The rates of downstream testing after initial ETT is presented in figure 1.
conclusion: Patients referred for ETT by cardiologists are less likely to have additional downstream testing, particularly non-invasive imaging 
tests, than those referred by non-cardiologists. The lower rate of testing is mainly driven by a lower rate of downstream testing following positive or 
inconclusive ETT Results. While further outcomes data are needed, these findings may have important potential implications on resource utilization 
and cost.
